Meati, a maker of mycelium-based versions of chicken cutlets and steak, plans to raise a Series D next year, its CEO Phil Graves tells Axios exclusively.
Why it matters: The company has attracted capital, including a $100 million Series C-1 in May, as other meat alternative startups have struggled.
